标题
Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management
作者
关键词
-
出版物
Cells
Volume 10, Issue 6, Pages 1377
出版商
MDPI AG
发表日期
2021-06-02
DOI
10.3390/cells10061377
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- “The use of bisphosphonates to treat skeletal complications in solid tumours”
- (2021) S. D’Oronzo- et al. BONE
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Limonoid Triterpene, Obacunone Increases Runt-Related Transcription Factor 2 to Promote Osteoblast Differentiation and Function
- (2021) Kyung-Ran Park et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Simultaneously targeting cancer-associated fibroblasts and angiogenic vessel as a treatment for TNBC
- (2021) Malvika Sharma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Osteoclast-derived small extracellular vesicles induce osteogenic differentiation via inhibiting ARHGAP1
- (2021) Mengmeng Liang et al. Molecular Therapy-Nucleic Acids
- Mice lacking DKK1 in T cells exhibit high bone mass and are protected from estrogen-deficiency-induced bone loss
- (2021) Juliane Lehmann et al. iScience
- Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
- (2021) Elham Sajjadi et al. Cancer Cell International
- Rethinking the clinical management of volumetric muscle loss in patients with spinal cord injury: Synergy among nutritional supplementation, pharmacotherapy, and rehabilitation
- (2021) Marco Invernizzi et al. CURRENT OPINION IN PHARMACOLOGY
- A novel mouse model for SNP in Steroid Receptor Co-activator-1 reveals role in bone density and breast cancer metastasis
- (2021) Rebecca J Watters et al. ENDOCRINOLOGY
- Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor‐positive, HER2 ‐negative metastatic breast cancer
- (2021) Hyehyun Jeong et al. INTERNATIONAL JOURNAL OF CANCER
- Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases
- (2021) Peter Burckhardt et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The human WNT5A isoforms display similar patterns of expression but distinct and overlapping activities in normal human osteoblasts
- (2021) Dristi Bhandari et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer
- (2021) Xiaoqing Sun et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeted therapy to β3 integrin reduces chemoresistance in breast cancer bone metastases
- (2021) Gregory C. Fox et al. MOLECULAR CANCER THERAPEUTICS
- SLPI is a critical mediator that controls PTH-induced bone formation
- (2021) Akito Morimoto et al. Nature Communications
- PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
- (2021) Nicola Fusco et al. Frontiers in Oncology
- Understanding the biology of volumetric muscle loss for an individualized exercise rehabilitation approach in breast cancer patients
- (2021) Marco Invernizzi et al. CURRENT OPINION IN PHARMACOLOGY
- Real-world use of denosumab and bisphosphonates in patients with solid tumours and bone metastases in Germany
- (2020) Ingo Diel et al. SUPPORTIVE CARE IN CANCER
- RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies
- (2020) Xiaoqiu Wu et al. Frontiers in Cell and Developmental Biology
- Efficacy evaluation and mechanism study on inhibition of breast cancer cell growth by multimodal targeted nanobubbles carrying AMD070 and ICG
- (2020) Daijia Shen et al. NANOTECHNOLOGY
- Spinal Cord Injury as a Model of Bone-Muscle Interactions: Therapeutic Implications From in vitro and in vivo Studies
- (2020) Marco Invernizzi et al. Frontiers in Endocrinology
- Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study
- (2020) Soojung Hong et al. PLoS One
- Breast Cancer Survivorship, Quality of Life, and Late Toxicities
- (2020) Simone Nardin et al. Frontiers in Oncology
- Cathepsin K: The Action in and Beyond Bone
- (2020) Rongchen Dai et al. Frontiers in Cell and Developmental Biology
- Osteoclast Signal Transduction During Bone Metastasis Formation
- (2020) Dávid S. Győri et al. Frontiers in Cell and Developmental Biology
- Influence of the TGF-β Superfamily on Osteoclasts/Osteoblasts Balance in Physiological and Pathological Bone Conditions
- (2020) Jessica Jann et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mechanisms of RANKL delivery to the osteoclast precursor cell surface
- (2020) Masashi Honma et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Osteoclast differentiation by RANKL and OPG signaling pathways
- (2020) Nobuyuki Udagawa et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Mouse 4T1 Breast Cancer Cell–Derived Exosomes Induce Proinflammatory Cytokine Production in Macrophages via miR-183
- (2020) Jian Guo et al. JOURNAL OF IMMUNOLOGY
- Bone metastasis is associated with acquisition of mesenchymal phenotype and immune suppression in a model of spontaneous breast cancer metastasis
- (2020) Lea Monteran et al. Scientific Reports
- CXCR4 Antagonist AMD3100 Reverses the Resistance to Tamoxifen in Breast Cancer via Inhibiting AKT Phosphorylation
- (2020) Jun Zhou et al. Molecular Therapy-Oncolytics
- Diagnosis and Treatment of Bone Metastases in Breast Cancer: Radiotherapy, Local Approach and Systemic Therapy in a Guide for Clinicians
- (2020) Fabio Marazzi et al. Cancers
- The CXCR4-Dependent LASP1-Ago2 Interaction in Triple-Negative Breast Cancer
- (2020) Augustus M. C. Tilley et al. Cancers
- The Signaling Duo CXCL12 and CXCR4: Chemokine Fuel for Breast Cancer Tumorigenesis
- (2020) Karolina A. Zielińska et al. Cancers
- The lingering mysteries of metastatic recurrence in breast cancer
- (2020) Alessandra I. Riggio et al. BRITISH JOURNAL OF CANCER
- Suppressive effects of an apoptotic mimicry prepared from jumbo-flying squid-skin phospholipids on the osteoclastogenesis in receptor activator of nuclear factor kappa B ligand/macrophage colony-stimulating factor-induced RAW 264.7 cells
- (2020) Yi-Feng Kao et al. Journal of the Chinese Medical Association
- Different roles of matrix metalloproteinase 2 in osteolysis of skeletal dysplasia and bone metastasis (Review)
- (2020) Xiumao Li et al. Molecular Medicine Reports
- Editorial: Quality of Life in Breast Cancer Patients and Survivors
- (2020) Marco Invernizzi et al. Frontiers in Oncology
- Molecular Insights into the Classification of Luminal Breast Cancers: The Genomic Heterogeneity of Progesterone-Negative Tumors
- (2019) Gianluca Lopez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of Bisphosphonates in Breast Cancer Therapy
- (2019) Hadar Goldvaser et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Bad to the Bone: The Role of the Insulin-Like Growth Factor Axis in Osseous Metastasis
- (2019) Guillaume Rieunier et al. CLINICAL CANCER RESEARCH
- IL-11 is essential in promoting osteolysis in breast cancer bone metastasis via RANKL-independent activation of osteoclastogenesis
- (2019) Mengmeng Liang et al. Cell Death & Disease
- Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
- (2019) Aradhana Rani et al. Frontiers in Endocrinology
- TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
- (2019) Yang Hao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Selective FGFR inhibitor AZD4547 suppresses RANKL/M-CSF/OPG-dependent ostoclastogenesis and breast cancer growth in the metastatic bone microenvironment
- (2019) Jinho Kang et al. Scientific Reports
- Combinatorial targeting of cancer bone metastasis using mRNA engineered stem cells
- (2019) Aude I. Segaliny et al. EBioMedicine
- Metastasis as a systemic disease: molecular insights and clinical implications
- (2019) Maša Alečković et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Incidence of skeletal-related events in patients with breast or prostate cancer-induced bone metastasis or multiple myeloma: A 12-year longitudinal nationwide healthcare database study
- (2019) Yeon-Hee Baek et al. Cancer Epidemiology
- A CTGF‐RUNX2‐RANKL Axis in Breast and Prostate Cancer cells Promotes Tumor Progression in Bone
- (2019) Bongjun Kim et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
- (2019) Yiran Liang et al. SEMINARS IN CANCER BIOLOGY
- The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer
- (2019) Ru Wang et al. BMC CANCER
- Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers
- (2019) Fabio Pagni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Preparation Of Nanobubbles Modified With A Small-Molecule CXCR4 Antagonist For Targeted Drug Delivery To Tumors And Enhanced Ultrasound Molecular Imaging
- (2019) Yanli Peng et al. International Journal of Nanomedicine
- Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
- (2019) Michael R McClung et al. Lancet Diabetes & Endocrinology
- Structure–Function Relationship and Physiological Roles of Transient Receptor Potential Canonical (TRPC) 4 and 5 Channels
- (2019) Jinsung Kim et al. Cells
- Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing RANKL Expression
- (2018) Yang Liu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Breast cancer bone metastases: pathogenesis and therapeutic targets
- (2018) Naomi Brook et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Parathyroid Hormone-Related Peptide Elicits Peripheral TRPV1-dependent Mechanical Hypersensitivity
- (2018) Andrew J. Shepherd et al. Frontiers in Cellular Neuroscience
- Bone metastasis pattern in initial metastatic breast cancer: a population-based study
- (2018) Zhenchong Xiong et al. Cancer Management and Research
- Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts
- (2018) Alison B. Shupp et al. Cancers
- Bone Remodeling and the Role of TRAF3 in Osteoclastic Bone Resorption
- (2018) Brendan F. Boyce et al. Frontiers in Immunology
- The biology of normal bone remodelling
- (2017) P. Katsimbri EUROPEAN JOURNAL OF CANCER CARE
- Clonal reticulohistiocytosis of the skin and bone marrow associated with systemic mastocytosis and acute myeloid leukaemia
- (2017) Nicola Fusco et al. HISTOPATHOLOGY
- Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases
- (2017) Andrew L. Himelstein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Validity of Osteoprotegerin and Receptor Activator of NF-κB Ligand for the Detection of Bone Metastasis in Breast Cancer
- (2017) Gamal A. Elfar et al. ONCOLOGY RESEARCH
- The production of fibroblast growth factor 23 is controlled by TGF-β2
- (2017) Martina Feger et al. Scientific Reports
- Integrin αvβ3 Signaling in Tumor-Induced Bone Disease
- (2017) Kristin Kwakwa et al. Cancers
- Upregulation of the S1P 3 receptor in metastatic breast cancer cells increases migration and invasion by induction of PGE 2 and EP 2 /EP 4 activation
- (2016) Iuliia Filipenko et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622
- (2016) Anne F. Schott et al. BREAST CANCER RESEARCH AND TREATMENT
- TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone Metastasis
- (2016) Z. Mitri et al. CLINICAL CANCER RESEARCH
- Role of the RANK/RANKL pathway in breast cancer
- (2016) Ludwig Kiesel et al. MATURITAS
- Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression
- (2016) Sangmin Kim et al. TUMOR BIOLOGY
- IL-1 drives breast cancer growth and bone metastasis in vivo
- (2016) Ingunn Holen et al. Oncotarget
- Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFR
- (2016) Tamara Aleksic et al. Frontiers in Oncology
- Trolox inhibits osteolytic bone metastasis of breast cancer through both PGE2-dependent and independent mechanisms
- (2014) Jong-Ho Lee et al. BIOCHEMICAL PHARMACOLOGY
- Breast Cancer Bone Metastases: It’s All about the Neighborhood
- (2013) Theresa A. Guise CELL
- Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial
- (2013) Dino Amadori et al. LANCET ONCOLOGY
- TGF 1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo
- (2011) F. Bouquet et al. CLINICAL CANCER RESEARCH
- The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial
- (2010) Anders Bonde Jensen et al. Clinical Breast Cancer
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates
- (2009) Karim Fizazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Bisphosphonates: Mechanism of Action and Role in Clinical Practice
- (2009) Matthew T. Drake et al. MAYO CLINIC PROCEEDINGS
- Imaging transforming growth factor-β signaling dynamics and therapeutic response in breast cancer bone metastasis
- (2009) Manav Korpal et al. NATURE MEDICINE
- Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment
- (2009) Lauren K. Dunn et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search